Factors to Weigh in While Administering Nitrous Oxide Anesthesia [Response to Letter].

Dear editor

Thank you for giving us the opportunity to respond to the publication in Clinical Ophthalmology entitled “Factors to weigh in while administering nitrous oxide anesthesia” by Shuja et al. We read with interest the letter to the Editor regarding the publication. This is our response to the three points raised by Shuja et al.

The first point is the use of nitrous oxide (N2O) anesthesia in patients with heart failure, hepatic dysfunction, and renal dysfunction. We perform preoperative electrocardiogram, chest x-ray, and blood test, and consult an internist to manage any abnormalities. Echocardiography is also performed when necessary. Additionally, we carefully monitor the vital signs of all patients, not only before, but also during and after surgery. Mitchell et al reported that N2O did not induce myocardial ischemia in patients with ischemic heart disease and poor ventricular function.1 The ENIGMA-II trial, a randomised, single-blind trial, showed no evidence that N2O increases the risk of cardiovascular complications after major non-cardiac surgery.2 We believe that 30% low-concentration N2O anesthesia can be safely used in patients with heart failure. Similarly, we also evaluate hepatic and renal function in blood tests preoperatively. Rahimzadeh described that N2O has been used in patients with advanced hepatic disease for many years without any complications.3 This suggests that N2O can be used safely in patients with hepatic disease. Although short operating time and low-concentration N2O anesthesia are thought to have little effect on the liver and kidney, chronic exposure to N2O anesthesia could cause hepatic and renal disease.4 When N2O anesthesia is used in ophthalmic surgery in the future, we should evaluate heart, liver, and kidney functions before and after surgery.

The second point is the preoperative amount of anesthesia. In our study,5 low-concentration N2O anesthesia was administered as a preoperative procedure, while topical anesthesia and sub-Tenon’s anesthesia were also performed as a preoperative procedure. We attempted to control intraoperative pain with preoperative topical, sub-Tenon’s, and N2O anesthesia. Currently, cataract surgery can usually be performed under local anesthesia with little pain. Srinivasan et al reported that pain score, which was evaluated by numerical ratings from 0 (no pain) to 10 (severe pain), immediately after cataract surgery was significantly lower (P=0.0043) in sub-Tenon’s anesthesia (2.42±2.2) than in topical anesthesia (3.44±2.3).6 In our study,5 all patients included received the same dosage of 4% xylocaine eye drop and 2% sub-Tenon’s anesthesia (2mL). Meanwhile, our study demonstrated that the preoperative anxiety level was higher in the N2O group (43.7±21.8) than in the Air group (34.2±28.2), although the difference was not significant (P=0.096).5 If, as Shuja et al point out, patients with higher preoperative anxiety require a higher dosage of anesthesia to reduce intraoperative pain, the N2O group should have greater intraoperative pain than the Air group. However, in our study,5 the intraoperative pain score was significantly lower (P=0.014) in the N2O group (12.4±14.9) than in the Air group (24.2±22.4). This also suggests that 30% low-concentration N2O anesthesia is effective at significantly reducing intraoperative patient pain.

The third point is the safety of N2O anesthesia. In our study,5 all patients included were preoperatively informed about the possibility of use of low-concentration N2O anesthesia during cataract surgery and the adverse effects of the anesthesia. N2O anesthesia has little effect on the respiratory system.7,8 In order to avoid adverse effects of N2O, the American Academy of Pediatric Dentistry recommends that the percentage of N2O delivered should not exceed 50% concentration during procedures.8 In general, diffusion hypoxia is not known to occur in cataract surgery with short operating time and 30% N2O;9 however, caution should be exercised when using more than 50% N2O. The most frequent adverse effects of N2O anesthesia are nausea and vomiting. The frequency of nausea and vomiting are as low as 3.7% with 50% N2O.10 Noguchi et al also reported that no patients experienced intraoperative nausea with 30% N2O during cataract surgery.11 Although 30% low-concentration N2O anesthesia is considered to have fewer adverse effects than 50% or higher concentrations of N2O, further studies are warranted to evaluate whether randomized controlled trials of the efficacy and safety of 30% low-concentration N2O anesthesia during cataract surgery are consistent with our results.5